| Market Capitalization (Millions $) |
12,740 |
| Shares
Outstanding (Millions) |
40 |
| Employees |
4,700 |
| Revenues (TTM) (Millions $) |
1,454 |
| Net Income (TTM) (Millions $) |
171 |
| Cash Flow (TTM) (Millions $) |
-135 |
| Capital Exp. (TTM) (Millions $) |
64 |
Business Description
Penumbra Inc. is a California-based medical device company that's focused on the development and manufacturing of innovative medical technologies for the treatment of neurological and vascular disorders. The company's portfolio of products includes neurovascular access, neurovascular intervention, neurointensive care, and related products for stroke and neurovascular disorders, including cerebral aneurysms, intracranial atherosclerosis, and traumatic brain injury.
Penumbra's history can be traced back to 2004 when it was founded by Dr. Adam Elsesser, an entrepreneur with a background in neuroscience and neurointervention. The company's name derives from the Latin word "penumbra," which refers to the partial shadow surrounding an area of complete darkness, symbolizing Penumbra's mission to bring light to dark and complex medical issues.
The company's flagship product, the Penumbra System, is a mechanical thrombectomy device that's used to remove blood clots from the brain during an ischemic stroke. This device has been a game-changer in the treatment of stroke, providing a safe and efficient alternative to traditional clot-busting drugs. Other notable products in Penumbra's portfolio include the 3D Revascularization Device, which provides mechanical support for the stent during large-vessel or complex aneurysm treatment, and the Neuron MAX System, which is used for rapid sealing of puncture holes following diagnostic or interventional neurovascular procedures.
In addition to its portfolio of medical devices, Penumbra has also developed a line of neurointensive care products, including catheters, drainage systems, and other devices that aid in the management of critically ill patients with neurological disorders. These products are designed to optimize patient outcomes and reduce complications during the recovery process.
Penumbra is committed to innovation and invests heavily in research and development to advance the quality and efficacy of its products. The company's state-of-the-art manufacturing and research facilities are located in Alameda, California, and its products are sold in over 100 countries worldwide.
Penumbra has won numerous awards and recognitions for its contributions to the field of medical technology, including the Galien USA Award for Best Medical Technology in 2011 and 2015. The company's commitment to excellence and innovation has helped make it a leader in the medical device industry and a driving force in the fight against neurovascular disorders.
Company Address: One Penumbra Place Alameda 94502 CA
Company Phone Number: 748-3200 Stock Exchange / Ticker: NYSE PEN
|
2.05% 
79.09 %